MarketBeat is providing analyst recommendations for two small-cap medical companies, Fortress Biotech and bioAffinity Technologies.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat is providing analyst recommendations for two small-cap medical companies, Fortress Biotech and bioAffinity Technologies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Fortress Biotech
company
Nothing else this week.
Related events
- Fortress Biotech and Milestone Pharmaceuticals are identified as small-cap healthcare companies.
- Eton Pharmaceuticals and Biofrontera, small-cap healthcare companies, are noted for their revenue and earnings, with MarketBeat providing analyst ratings.
- MarketBeat reported analyst recommendations, noting that both MarketBeat and Jefferies Financial Group are mid-cap finance companies.
- MarketBeat provided analyst recommendations and compared Organon & Co. and Xeris Biopharma.
- MarketBeat reported analyst recommendations for Cytokinetics and Gain Therapeutics, two competing healthcare companies.